Insulin infusion therapy for myocardial infarction

Bibliography

• LOWEL H, KOENIG W, ENGEL S, HORMANN A, KEIL U: The impact of diabetes mellitus on survival after myocardial infarction: can it be modified by drug treatment? Results of a population-based myocardial infarction register follow-up study. Diabetologia (2000) 43:218-226.
   PubMed Web of Science ®Google Scholar
• ARONSON D, RAYFIELD EJ, CHESEBRO JH: Mechanisms determining course and outcome of diabetic patients who have had acute myocardial infarction. Ann. Intern. Med. (1997) 126:296-306.
   PubMed Web of Science ®Google Scholar
• CAPES SE, HUNT D, MALMBERG K, GERSTEIN HC: Stress hyperglycemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet (2000) 355:773-778.
   PubMed Web of Science ®Google Scholar
• ALLISON SP, CHAMBERLAIN MJ, HINTON P: Intravenous glucose tolerance, insulin, glucose, and free fatty acid levels after myocardial infarction. Br. Med. J. (1969) 4:776-778.
   PubMedGoogle Scholar
• WONG V, ROSS DL, PARK K, BOYAGES S, CHEUNG NW: Hyperglycemia following acute myocardial infarction is a predictor of poor cardiac outcomes in the reperfusion era. Diab. Res. Clin. Pract. (2004) 64:85-91.
   PubMedGoogle Scholar
• KADRI Z, DANCHIN N, VAUR L et al.: Major impact of admission glycaemia on 30 day and one year mortality in non-diabetic patients admitted for myocardial infarction: results from the nationwide French USIC 2000 study. Heart (2006) 92:910-915.
   PubMedGoogle Scholar
• STRAUMANN E, KURZ DJ, MUNTWYLER J et al.: Admission glucose concentrations independently predict early and late mortality in patients with acute myocardial infarction treated by primary or rescue percutaneous coronary intervention. Am. Heart J. (2005) 150:1000-1006.
   PubMed Web of Science ®Google Scholar
• MEIER JJ, LAUNHARDT V, DEIFUSS A et al.: Plasma glucose at hospital admission and previous metabolic control determine myocardial infarct size ans survival in patients with and without Type 2 diabetes. Diabetes Care (2005) 28:2551-2553.
   PubMedGoogle Scholar
• STRANDERS I, DIAMANT M, VAN GELDER RE et al.: Admission blood glucose level as risk indicator of death after myocardial infarction in patients with and without diabetes mellitus. Arch. Int. Med. (2004) 164:982-988.
   PubMed Web of Science ®Google Scholar
• GOYAL A, MAHAFFEY KW, GARG J et al.: Prognostic significance of the change in glucose level in the first 24h after acute myocardial infarction: results from the CARDINAL study. Eur. Heart J. (2006) 27:1289-1297.
   PubMed Web of Science ®Google Scholar
• TIMMER JR, VAN DER HORST ICC, OTTERVANGER JP et al.: Prognostic value of admission glucose in non-diabetic patients with myocardial infarction. Am. Heart J. (2004) 148:399-404.
   PubMedGoogle Scholar
• STANLEY AW, JR., MORASKI RE, RUSSELL RO et al.: Effects of glucose-insulin-potassium on myocardial substrate availability and utilization in stable coronary artery disease. Studies on myocardial carbohydrate, lipid and oxygen arterial-coronary sinus differences in patients with coronary artery disease. Am. J. Cardiol. (1975) 36:929-937.
   PubMed Web of Science ®Google Scholar
• APSTEIN CS, TAEGTMEYER H: Glucose-insulin-potassium in acute myocardial infarction: the time has come for a large, prospective trial. Circulation (1997) 96:1074-1077.
   PubMedGoogle Scholar
• FATH-ORDOUBADI F, BEATT KJ: Glucose-insulin-potassium therapy for treatment of acute myocardial infarction: an overview of randomized placebo-controlled trials. Circulation (1997) 96:1152-1156.
   PubMed Web of Science ®Google Scholar
• DIAZ R, PAOLASSO EC, PIEGAS LS et al.: Metabolic modulation of acute myocardial infarction: the ECLA glucose-insulin-potassium pilot trial. Circulation (1998) 98:2227-2234.
   PubMed Web of Science ®Google Scholar
• CEREMUZYNSKI L, BUDAJ A, CZEPIEL A et al.: Low-dose glucose-insulin-potassium is ineffective in acute myocardial infarction: results of a randomized multicenter Pol-GIK trial. Cardiovasc. Drugs. Ther. (1999) 13:191-200.
   PubMed Web of Science ®Google Scholar
• VAN Der HORST ICC, ZIJLSTRA F, VAN’T HOF AWJ et al.: Glucose-insulin-potassium infusion in patients treated with primary angioplasty for acute myocardial infarction. J. Am. Coll. Cardiol. (2003) 42:784-791.
   PubMedGoogle Scholar
• TIMMER JR, SVILAAS T, OTTERVANGER JP et al.: Glucose-insulin-potassium infusion in patients with acute myocardial infarction without signs of myocardial infarction: the Glucose-Insulin-Potassium Study (GIPS)-II. J. Am. Coll. Cardiol. (2006) 47(8):1730-1731.
   PubMedGoogle Scholar
• THE CREATE-ECLA TRIAL GROUP INVESTIGATORS: Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction. JAMA (2005) 293:437-446.
   PubMed Web of Science ®Google Scholar
• APSTEIN CS, OPIE LH: A challenge to the metabolic approach to myocardial ischaemia. Eur. Heart J. (2005) 26:956-959.
   PubMedGoogle Scholar
• ADDO TA, KEELEY EC, CIGARROA JE et al.: Effect of glucose-insulin-potassium infusion on plasma free fatty acid concentrations in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction. Am. J. Cardiol. (2004) 94:1288-1289.
   PubMedGoogle Scholar
• CHAUDHURI A, JANICKE D, WILSON MF et al.: Anti-inflammatory and prothrombolytic effect of insulin in acute ST-segment-elevation myocardial infarction. Circulation (2004) 109:849-854.
   PubMed Web of Science ®Google Scholar
• ZHYANG L, ZHANG L, LI YH et al.: High-dose glucose-insulin-potassium treatment reduces myocardial apoptosis in patients with acute myocardial infarction. Eur. J. Clin. Invest. (2005) 35:164-170.
   PubMedGoogle Scholar
• ESPOSITO K, NAPPO F, MARFELLA R et al.: Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation (2002) 106:2067-2072.
   PubMed Web of Science ®Google Scholar
• MARFELLA R, SINISCALCHI M, ESPOSITO K et al.: Effects of stress hyperglycemia on acute myocardial infarction: role of inflammatory immune process in functional cardiac outcome. Diabetes Care (2003) 26:3129-3135.
   PubMed Web of Science ®Google Scholar
• SHIZUKUDA Y, REYLAND ME, BUTTRICK PM: Protein kinase C-delta modulates apoptosis induced by hyperglycemia in adult ventricular myocytes. Am. J. Physiol. Heart Circ. Physiol. (2002) 282:H1625-H1634.
   PubMedGoogle Scholar
• NISHIKAWA T, EDELSTEIN D, DU XL et al.: Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature (2000) 404:787-790.
   PubMed Web of Science ®Google Scholar
• MOHANTY P, HAMOUDA W, GARG R et al.: Glucose challenge stimulates reactive oxygen species (ROS) generation by leucocytes. J. Clin. Endocrinol. Metab. (2000) 85:2970-2973.
   PubMed Web of Science ®Google Scholar
• MONNIER L, MAS E, GINET C et al.: Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with Type 2 diabetes. JAMA (2006) 295:1681-1687.
   PubMed Web of Science ®Google Scholar
• AVOGARO A, VIGILI DE KREUTZENBERG S, NEGUT C, TIENGO A, SCOGNAMIGLIO R: Diabetic cardiomyopathy: a metabolic perspective. Am. J. Cardiol. (2004) 93(Suppl.):13A-16A.
   PubMed Web of Science ®Google Scholar
• MALMBERG K, RYDEN L, EFENDIC S et al.: Randomised trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI Study): effects on mortality at 1 year. J. Am. Coll. Cardiol. (1995) 26:57-65.
   PubMed Web of Science ®Google Scholar
• MALMBERG K, EFENDIC S, RYDEN L: Feasibility of insulin-glucose infusion in diabetic patients with acute myocardial infarction. Diabetes Care (1994) 17:1007-1014.
   PubMedGoogle Scholar
• MALMBERG K: Prospective randomized study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus. Br. Med. J. (1997) 314:1512-1515.
   PubMed Web of Science ®Google Scholar
• BRADY PA, TERZIC A: The sulfonylurea controversy: more questions from the heart. J. Am. Coll. Cardiol. (1998) 31:950-956.
   PubMed Web of Science ®Google Scholar
• MALMBERG K, RYDEN L, WEDEL H et al.: Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2); effects on mortality and morbidity. Eur. Heart. J. (2005) 26:650-661.
   PubMed Web of Science ®Google Scholar
• CHEUNG NW, WONG V, MCLEAN M: The Hyperglycemia: Intensive Insulin Infusion In Infarction (HI-5) Study – a randomised controlled trial of insulin infusion therapy for myocardial infarction. Diabetes Care (2006) 29:765-770.
   PubMed Web of Science ®Google Scholar
• WONG V, MCLEAN M, BOYAGES S, CHEUNG NW: CRP levels following acute myocardial infarction. Effect of insulin infusion and tight glycemic control. Diabetes Care (2004) 27:2971-2973.
   PubMed Web of Science ®Google Scholar
• CLARK RS, ENGLISH M, MCNEILL GP, NEWTON RW: Effect of intravenous infusion of insulin in diabetics with acute myocardial infarction. Br. Med. J. (1985) 291:303-305.
   PubMed Web of Science ®Google Scholar
• VAN DEN BERGHE G, WOUTERS P, WEEKERS F et al.: Intensive insulin therapy in critically ill patients. N. Engl. J. Med. (2001) 345:1359-1367.
   PubMed Web of Science ®Google Scholar
• VAN DEN BERGHE G, WILMER A, HERMANS G et al.: Intensive insulin therapy in the medical ICU. N. Engl. J. Med. (2006) 354:449-461.
   PubMed Web of Science ®Google Scholar
• VAN DEN BERGHE G, WOUTERS P, BOUILLON R et al.: Outcome of intensive insulin therapy in the critically ill: insulin dose versus glycaemic control. Crit. Care. Med. (2003) 31:359-366.
   PubMed Web of Science ®Google Scholar